April 2, 2015, Thursday 1:00pm to 5:00pm
FDA White Oak Campus Great Room (Rm. 1503)
10903 New Hampshire Ave. Silver Spring, MD 20993-0002
Do you live in the Maryland-Washington DC area? Are you interested in advocacy for metastatic breast cancer patients?
Consider joining several MBCN members who will be speaking at this FDA meeting on April 2. The FDA will ask for patient comment on important breast cancer questions (treatment symptoms, downsides to treatments, supportive care treatments, goals for treatment, prolonging life versus improving the symptoms, factors considered when making decisions about using treatments, weighing potential benefits of treatments vs. common side effects of treatments and serious risks associated with the treatments).
Currently, there is the opportunity to attend in person or through a webinar connection. Comments may be submitted in person or in writing to the FDA. The following is a link to the meeting information/registration:
Note: this is a great opportunity to participate in a fact finding FDA forum and is not a call for protests or demonstrations.
If you are planning on attending in person, please let us know, so we can meet. Email us at
|